Medicine & Life Sciences
Erlotinib Hydrochloride
80%
Microtubules
61%
ErbB Receptors
60%
Cytotoxins
58%
Protein-Tyrosine Kinases
57%
Lung Neoplasms
49%
Cell Line
37%
Adenosine Triphosphate
24%
entinostat
17%
Vinorelbine
14%
Histone Deacetylase Inhibitors
12%
Docetaxel
11%
gemcitabine
11%
Adenocarcinoma of Lung
11%
Epithelial-Mesenchymal Transition
10%
Paclitaxel
10%
Immunoblotting
10%
Cisplatin
9%
Small Interfering RNA
8%
Neoplasms
6%
Gene Expression
6%
In Vitro Techniques
4%
Pharmaceutical Preparations
4%
Therapeutics
3%
Agriculture & Biology
epidermal growth factor receptors
84%
lung neoplasms
82%
microtubules
59%
neoplasm cells
57%
tyrosine
57%
phosphotransferases (kinases)
54%
cell lines
46%
histone deacetylase
14%
cisplatin
13%
cells
13%
paclitaxel
13%
adenocarcinoma
12%
small interfering RNA
12%
immunoblotting
10%
lungs
8%
therapeutics
8%
drugs
6%
gene expression
6%
Chemical Compounds
Erlotinib
100%
Phosphotransferase Inhibitor
66%
Cytotoxic Agent
65%
Resistance
39%
Entinostat
23%
Vinorelbine
18%
Gemcitabine
15%
Silencing RNA
13%
Paclitaxel
12%
Cisplatin
11%
Histone
11%
Drug
5%